Daniel I Feig

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. doi request reprint Sugar-sweetened beverages and hypertension
    Daniel I Feig
    Baylor College of Medicine, 1102 Bates Street, Ste 260, Houston, TX 77030, USA
    Future Cardiol 6:773-6. 2010
  2. pmc Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Daniel I Feig
    Baylor College of Medicine and Texas Children s Hospital, Houston, Texas 77030, USA
    Curr Opin Nephrol Hypertens 18:526-30. 2009
  3. ncbi request reprint Serum uric acid: a risk factor and a target for treatment?
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    J Am Soc Nephrol 17:S69-73. 2006
  4. ncbi request reprint Uric acid and hypertension
    Daniel I Feig
    Department of Pediatrics, Renal Section, MC3 2482, Baylor College of Medicine, 1102 Bates Street, Houston, TX 77030, USA
    Curr Hypertens Rep 8:111-5. 2006
  5. pmc Uric acid and cardiovascular risk
    Daniel I Feig
    Baylor College of Medicine, Houston, TX 77030, USA
    N Engl J Med 359:1811-21. 2008
  6. doi request reprint Uric acid reduction rectifies prehypertension in obese adolescents
    Beth Soletsky
    Baylor College of Medicine, Department of Pediatrics, Renal Section, Houston, TX, USA
    Hypertension 60:1148-56. 2012
  7. doi request reprint Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children
    Sarah J Swartz
    Department of Pediatrics, Renal Section, Baylor College of Medicine, 6621 Fannin St, MC3 2482, Houston, TX 77030, USA
    Pediatrics 122:1177-81. 2008
  8. pmc Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    JAMA 300:924-32. 2008
  9. pmc The role of uric acid in pediatric hypertension
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, Texas 77030, USA
    J Ren Nutr 17:79-83. 2007
  10. doi request reprint Association between left ventricular mass index and cardiac function in pediatric dialysis patients
    Pirouz Shamszad
    Department of Pediatrics, Lillie Frank Abercrombie Section of Cardiology, Baylor College of Medicine, 6621 Fannin St, MC 19345 C, Houston, 77030, TX, USA
    Pediatr Nephrol 27:835-41. 2012

Detail Information

Publications18

  1. doi request reprint Sugar-sweetened beverages and hypertension
    Daniel I Feig
    Baylor College of Medicine, 1102 Bates Street, Ste 260, Houston, TX 77030, USA
    Future Cardiol 6:773-6. 2010
    ..8 mmHg reduction in systolic blood pressure and an average of 1.1 mmHg reduction in diastolic blood pressure...
  2. pmc Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Daniel I Feig
    Baylor College of Medicine and Texas Children s Hospital, Houston, Texas 77030, USA
    Curr Opin Nephrol Hypertens 18:526-30. 2009
    ..To assess the current data suggesting that uric acid-lowering therapy may be useful in the prevention or mitigation of chronic kidney disease (CKD)...
  3. ncbi request reprint Serum uric acid: a risk factor and a target for treatment?
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    J Am Soc Nephrol 17:S69-73. 2006
    ..Although the investigations are still preliminary, serum uric acid represents a possible new and intriguing target for the reduction of morbidity and mortality associated with hypertension and CV disease...
  4. ncbi request reprint Uric acid and hypertension
    Daniel I Feig
    Department of Pediatrics, Renal Section, MC3 2482, Baylor College of Medicine, 1102 Bates Street, Houston, TX 77030, USA
    Curr Hypertens Rep 8:111-5. 2006
    ..Ongoing clinical trials will elucidate the role of uric acid in human hypertension and will determine whether control of uric acid may be a new way to prevent or treat essential hypertension...
  5. pmc Uric acid and cardiovascular risk
    Daniel I Feig
    Baylor College of Medicine, Houston, TX 77030, USA
    N Engl J Med 359:1811-21. 2008
  6. doi request reprint Uric acid reduction rectifies prehypertension in obese adolescents
    Beth Soletsky
    Baylor College of Medicine, Department of Pediatrics, Renal Section, Houston, TX, USA
    Hypertension 60:1148-56. 2012
    ..These data indicate that, at least in adolescents with prehypertension, uric acid causes increased BP that can be mitigated by urate lowering therapy...
  7. doi request reprint Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children
    Sarah J Swartz
    Department of Pediatrics, Renal Section, Baylor College of Medicine, 6621 Fannin St, MC3 2482, Houston, TX 77030, USA
    Pediatrics 122:1177-81. 2008
    ..The goal was to determine the cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of stage 1 hypertension...
  8. pmc Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    JAMA 300:924-32. 2008
    ..Experimentally increasing uric acid levels using a uricase inhibitor causes systemic hypertension in animal models...
  9. pmc The role of uric acid in pediatric hypertension
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, Texas 77030, USA
    J Ren Nutr 17:79-83. 2007
    ..Future studies will be needed to determine whether the mechanisms shown in animal models can be extrapolated to children...
  10. doi request reprint Association between left ventricular mass index and cardiac function in pediatric dialysis patients
    Pirouz Shamszad
    Department of Pediatrics, Lillie Frank Abercrombie Section of Cardiology, Baylor College of Medicine, 6621 Fannin St, MC 19345 C, Houston, 77030, TX, USA
    Pediatr Nephrol 27:835-41. 2012
    ..LVMI has not been linked to cardiovascular endpoints in children. The aim of this study was to identify an association between elevated LVMI and echocardiographic markers of systolic and diastolic function...
  11. pmc Hyperuricemia in childhood primary hypertension
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    Hypertension 42:247-52. 2003
    ..These results are consistent with the hypothesis that uric acid might have a role in the early pathogenesis of primary hypertension...
  12. ncbi request reprint Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
    Daniel I Feig
    Renal Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    Kidney Int 66:281-7. 2004
    ..Genetic, physiologic, and epidemiologic studies provide clues to its origins, but a clear understanding has been elusive. Recent experimental and clinical studies have implicated uric acid in the onset of essential hypertension...
  13. ncbi request reprint Uric acid and hypertension in adolescents
    Daniel I Feig
    Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX 77030, USA
    Semin Nephrol 25:32-8. 2005
    ....
  14. ncbi request reprint Inaccuracy in pediatric outpatient blood pressure measurement
    Amber Podoll
    Cardiology Section, Baylor College of Medicine, Houston, TX 77030, USA
    Pediatrics 119:e538-43. 2007
    ..quot;..
  15. doi request reprint Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children
    Christopher A Thomas
    Department of Pharmacy, Texas Children s Hospital, Houston, Texas, USA
    Pediatr Crit Care Med 12:28-32. 2011
    ..To determine the efficacy and safety of labetalol for hypertensive crisis in children ≤ 24 months of age...
  16. doi request reprint Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome
    Sarah J Swartz
    Renal Division, Department of Pediatrics, Baylor College of Medicine, 6621 Fannin St, MC3 2482, Houston, TX 77030, USA
    Pediatr Nephrol 24:1187-92. 2009
    ..IgM+ IF may be surrogate marker for the severity of MCD. Based on our results, children with MCD and IgM+ IF have a better response to cyclosporine than cyclophosphamide...
  17. ncbi request reprint Childhood hypertension is not a silent disease
    Beth Croix
    Renal Section, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    Pediatr Nephrol 21:527-32. 2006
    ..001). We conclude that newly diagnosed hypertensive children had a variety of non-specific symptoms, more prevalent than those of normotensive children, and most somatic complaints improved with 4-6 months of anti-hypertensive treatment...
  18. ncbi request reprint Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis
    Stuart L Goldstein
    Department of Pediatrics, Renal, Baylor College of Medicine, Houston, TX, USA
    Pediatr Nephrol 23:129-35. 2008
    ..Variable changes in proinflammatory cytokine levels were observed. We suggest that frequent HD with the NxStage system be considered for children who would benefit from home-based maintenance dialysis...